title: [Patent ductus arteriosus. A common clinical problem in extremely premature infants].
abstract: An analysis was made of the incidence and treatment regimen of symptomatic patent ductus arteriosus (PDA) in 95 preterm infants treated 1997-1999 in a level three intensive care unit in Stockholm. 47 infants (49 percent) had PDA. Of these 17 infants were managed conservatively (fluid restriction and diuretics), 13 were treated with indomethacin, 10 underwent primary surgical ligation and 7 were treated with indomethacin first and surgery later on. The proportion of infants given "active" therapy (surgery and/or indomethacin) rose from 50 percent in 1997 to 85 percent in 1999. In a stepwise multiple regression analysis low birthweight, septicaemia and need for mechanical ventilation were all independently associated with PDA.
authors.affiliation: Länssjukhuset Gävle-Sandviken.
authors.forename: A K
authors.initials: AK
authors.lastname: Edstedt-Bonamy
authors.forename: S
authors.initials: S
authors.lastname: Johansson
authors.forename: J
authors.initials: J
authors.lastname: Milerad
mesh_terms: D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage; D004374:Ductus Arteriosus, Patent / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D005440:Fluid Therapy; D006801:Humans; D015994:Incidence; D007213:Indomethacin / Q000008:administration & dosage; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D015931:Intensive Care, Neonatal / Q000379:methods; D013514:Surgical Procedures, Operative / Q000379:methods; D013548:Sweden / Q000453:epidemiology
chemical_list: D016861:Cyclooxygenase Inhibitors; D007213:Indomethacin